HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histidine provides long-term neuroprotection after cerebral ischemia through promoting astrocyte migration.

Abstract
The formation of glial scar impedes the neurogenesis and neural functional recovery following cerebral ischemia. Histamine showed neuroprotection at early stage after cerebral ischemia, however, its long-term effect, especially on glial scar formation, hasn't been characterized. With various administration regimens constructed for histidine, a precursor of histamine, we found that histidine treatment at a high dose at early stage and a low dose at late stage demonstrated the most remarkable long-term neuroprotection with decreased infarct volume and improved neurological function. Notably, this treatment regimen also robustly reduced the glial scar area and facilitated the astrocyte migration towards the infarct core. In wound-healing assay and transwell test, histamine significantly promoted astrocyte migration. H2 receptor antagonists reversed the promotion of astrocyte migration and the neuroprotection provided by histidine. Moreover, histamine upregulated the GTP-bound small GTPase Rac1, while a Rac1 inhibitor, NSC23766, abrogated the neuroprotection of histidine and its promotion of astrocyte migration. Our data indicated that a dose/stage-dependent histidine treatment, mediated by H2 receptor, promoted astrocyte migration towards the infarct core, which benefited long-term post-cerebral ischemia neurological recovery. Therefore, targeting histaminergic system may be an effective therapeutic strategy for long-term cerebral ischemia injury through its actions on astrocytes.
AuthorsRu-jia Liao, Lei Jiang, Rong-rong Wang, Hua-wei Zhao, Ying Chen, Ya Li, Lu Wang, Li-Yong Jie, Yu-dong Zhou, Xiang-nan Zhang, Zhong Chen, Wei-wei Hu
JournalScientific reports (Sci Rep) Vol. 5 Pg. 15356 (Oct 20 2015) ISSN: 2045-2322 [Electronic] England
PMID26481857 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neuroprotective Agents
  • Receptors, Histamine H2
  • Histidine
  • rac1 GTP-Binding Protein
Topics
  • Animals
  • Astrocytes (drug effects, metabolism)
  • Brain Ischemia (drug therapy, metabolism, pathology, physiopathology)
  • Cell Movement (drug effects)
  • Cicatrix (pathology)
  • Cognition (drug effects)
  • Disease Models, Animal
  • Histidine (metabolism, pharmacology)
  • Male
  • Neuroprotection (drug effects)
  • Neuroprotective Agents (pharmacology)
  • Rats
  • Receptors, Histamine H2 (metabolism)
  • Recovery of Function (drug effects)
  • Wound Healing (drug effects)
  • rac1 GTP-Binding Protein (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: